All Keywords
【저자키워드】 Immunotherapy, HIV, Human immunodeficiency virus, IVIG, intravenous immunoglobulin, HCQ, hydroxychloroquine, Rowell syndrome, anifrolumab, MMF, Mycophenolate mofetil, SLE, Systemic lupus erythematous, CLE, cutaneous lupus erythematosus, DIF, direct immunofluorescence, SCLE, subacute cutaneous lupus erythematosus, BAFF, B cell-activating factor, cutaneous lupus erythematous, DLE, discoid lupus erythematosus, EM, erythema multiforme, HAART, highly active antiretroviral therapy, IL, intralesional, LE, lupus erythematosus, PIPA, post inflammatory pigment alteration, RS, Rowell syndrome, IFNAR1, interferon- α receptor 1,
【저자키워드】 Immunotherapy, HIV, Human immunodeficiency virus, IVIG, intravenous immunoglobulin, HCQ, hydroxychloroquine, Rowell syndrome, anifrolumab, MMF, Mycophenolate mofetil, SLE, Systemic lupus erythematous, CLE, cutaneous lupus erythematosus, DIF, direct immunofluorescence, SCLE, subacute cutaneous lupus erythematosus, BAFF, B cell-activating factor, cutaneous lupus erythematous, DLE, discoid lupus erythematosus, EM, erythema multiforme, HAART, highly active antiretroviral therapy, IL, intralesional, LE, lupus erythematosus, PIPA, post inflammatory pigment alteration, RS, Rowell syndrome, IFNAR1, interferon- α receptor 1,